Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.3.0.814
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Revenues, net:        
Product $ 2,979,834 $ 3,122,164 $ 8,289,596 $ 8,251,764
Recurring 1,077,586 960,509 3,097,844 2,816,874
Total Net Revenue 4,057,420 4,082,673 11,387,440 11,068,638
Cost of Sales:        
Product 1,513,727 1,674,172 4,286,144 5,000,490
Recurring 253,394 266,136 727,665 783,521
Total Cost of Sales 1,767,121 1,940,308 5,013,809 5,784,011
Gross Profit 2,290,299 2,142,365 6,373,631 5,284,627
Operating Expenses:        
Research and development 373,710 347,344 1,128,596 962,849
Selling, general and administrative 1,512,080 1,267,968 4,785,045 4,096,314
Depreciation and amortization 67,494 69,525 205,515 205,711
Total Operating Expenses 1,953,284 1,684,837 6,119,156 5,264,874
Income from Operations 337,015 457,528 254,475 19,753
Other Income (Expenses):        
Interest income (expense), net (16,283) (6,072) (50,786) (24,796)
Total Other Income (Expense) (16,283) (6,072) (50,786) (24,796)
Income (Loss) Before Provision for Income Taxes 320,732 451,456 203,689 (5,043)
Provision for Income Taxes 51,312 68,706 154,836 171,330
Net Income (Loss) 269,420 382,750 48,853 (176,373)
Accretion of preferred dividends and discount 0 (36,166) (18,253) (107,890)
Net income (loss) attributable to common stockholders $ 269,420 $ 346,584 $ 30,600 $ (284,263)
Net income (loss) per common share:        
Net income (loss) attributable to common stockholders per common share - basic $ 0.00 $ 0.00 $ 0.00 $ 0.00
Net income (loss) attributable to common stockholders per common share - diluted $ 0.00 $ 0.00 $ 0.00 $ 0.00
Weighted Average Common Shares Outstanding - basic 126,411,243 125,035,612 125,499,195 125,035,612
Weighted Average Common Shares Outstanding - diluted 128,929,552 126,814,401 125,539,532 125,035,612